Cures Within Reach Hires Clare Thibodeaux as Director of Scientific Affairs

SKOKIE, Ill. - Nov. 18, 2015 - PRLog -- Cures Within Reach, an organization working exclusively to catalyze repurposing research to quickly and affordably improve patient lives, welcomes Clare Thibodeaux to its leadership team as Director of Scientific Affairs.

“We are excited to have Clare join our team,” said Dr. Bruce Bloom, President and Chief Science Officer at Cures Within Reach. “Her lab research in cancer coupled with her market research experience will help us achieve our mission of improving patient quality and length of life through repurposing reserach."

In her new role at Cures Within Reach, Clare will oversee the repurposing research sourcing, review and selection process for the organization and within the CureAccelerator™ platform. She is also charged with strengthening and growing the organization’s Science Advisory Board, Research Institutional Partner Network and all science-related programing.

Clare Thibodeaux, Ph.D., M.B.A., comes to Cures Within Reach after serving as a high-level volunteer for American Cancer Society where she represented interests of cancer patients, led advocacy efforts and implemented strategic communications, community outreach and logistical plans.

Clare has over ten years experience in cancer-related issues. She has conducted original research in a university setting, advocated with state and federal elected officials and engaged the general public through community outreach. Prior to her involvement in the biomedical field, Clare was a market research professional. She has designed and managed market research projects for several trade associations and professional societies, creating actionable information from research data.

She has also led various committees and boards through her volunteer work with the American Cancer Society. Clare holds a Ph.D. in Tumor Biology from Georgetown University, a Master of Business Administration from George Mason University, and a B.A. in Mathematics from the University of Michigan.

ABOUT CURES WITHIN REACH

Cures Within Reach works to catalyze repurposing research to quickly and affordably improve patient lives. We accomplish this through collaborations that connect researchers and funding, by facilitating crowd sourcing and community, and by identifying alternative financing models and incentives.

Cures Within Reach’s medical research projects have generated 12 repurposing treatments making an impact in the following diseases through off-label use in clinical practice or through a commercialization track: autoimmune lymphoproliferative syndrome, familial dysautonomia, Types 1 and 2 diabetes, lung cancer, multiple sclerosis, prostate cancer, myelodysplastic syndrome and 4 additional pediatric auto-immune diseases.

The organization uses CureAccelerator to support repurposing research that can deliver effective solutions to unsolved diseases. Cures Within Reach received a $500,000 grant from the Robert Wood Johnson Foundation to build CureAccelerator, the world’s first online, interactive platform dedicated to explore whether drugs, devices and nutriceuticals approved for one or more human diseases can be repurposed to create “new” treatments in other diseases.

Visit us at www.cureswithinreach.org or follow us via Twitter.com/CuresWReach (http://www.twitter.com/CuresWReach), YouTube.com/cureswithinreach (http://www.youtube.com/cureswithinreach) or Facebook.com/P4Cures (http://www.facebook.com/P4Cures)